Another piece of evidence comes from a study by Chang et al. [2], who revealed that miR-145 is downregulated when BMI1 is overexpressed, which boosts Sp1 expression and accelerates EMT in pemetrexed-resistant NSCLC cells [2]. The gene discussed is SP1; the disease is non-small cell lung carcinoma.